Everything below concerns melanocortin receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
| Property | Value | Notes |
|---|---|---|
| Compound class | Synthetic cyclic heptapeptide | Alpha-MSH analogue containing a D-phenylalanine residue |
| Molecular formula | C50H69N15O9 | Average molecular mass approximately 1024.2 g/mol |
| Appearance | White to off-white lyophilised powder | Normally supplied as a freeze-dried solid in a sealed vial |
| Solubility | Freely soluble in water and polar solvents | Dissolves readily in aqueous buffers and in alcohol-water mixtures |
| Receptor targets | MC1R, MC3R, MC4R, MC5R | Acts as a non-selective melanocortin receptor agonist |
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
A type of clinical trial in which only the doctor knows whether a patient is taking the standard treatment or the new treatment being tested. This helps prevent bias in treatment studies. (NCI) A study in which one party, either the investigator or participant, is unaware of what medication the participant is taking; also called single-masked study. (NLM) Source Data
=== Africa === The soybean first arrived in Africa via Egypt in 1857. Soya Meme (Baked Soya) is produced in the village called Bame Awudome near Ho, the capital of the Volta Region of Ghana, by the Ewe people of Southeastern Ghana and southern Togo.
analytical chemistry The branch of chemistry which studies and makes use of instruments and methods to separate, quantify, and identify chemical substances, both by classical wet chemistry techniques such as precipitation, extraction, distillation, and observational analysis, and by modern instrumental techniques such as chromatography, spectroscopy, and electrochemistry.
Valerie Joy Beynon. For services to the community in Cobham, Surrey. Elizabeth Kay Billington. Chair, Kushti Bok and Vice-Chair, Dorset Council Gypsy Traveller Forum. For services to the Gypsy and Traveller Community in Dorset. William Archibald Bingham. Chair, Newcastle and Mourne Cancer Research Committee. For services to Cancer Research Fundraising in County Down. Chandra Shekhar Biyani. Consultant Urological Surgeon, Leeds Teaching Hospitals NHS Trust. For services to Medical Education. Reverend Christine Fiona Blackman. For services to the community in Reading, Berkshire. Derek John Bland. For services to the community in Northamptonshire. Roberta Vivian Lindsay Blyth. For services to the community in Roade, Northamptonshire. Winifred Patricia Bownes. Volunteer Coordinator, Cookstown Monday Club. For services to the community in Cookstown, County Tyrone. Mary Boyes. Cleaner, North Shore Academy, Stockton-on-Tees. For services to Education. John Robert Boyne-Aitken. For services to Heritage Crafts. Evelyn Lettita Bracey. For services to the community in Wantage, Oxfordshire. Paul Mark Brackley. Community First Responder, Oundle Community First Responders. For services to the community in Oundle and North Northamptonshire. Christopher Samuel Bradbury. For services to the community in Reedham, Norfolk. Moira Jeanette Brock. Founder and Principal, La Danse Fantastique. For services to Young People in Basildon, Essex. Anna Theresa Margaret Brown. For services to the NHS and to the community in the London Borough of Richmond-upon-Thames. Dennis Sydney Brown.
Sources: en.wikipedia.org
Lulu Mall Hyderabad is a shopping mall located in Hyderabad, the capital city of Telangana, India. It is the first lulu mall in the state of Telangana, located in Kukatpally. The mall was inaugurated in September 2023 and houses shops for both domestic and international brands as well as a multi-cuisine food court, a theatre, and other amenities. The estimated cost for this project was more than ₹300 crore. The property is owned and managed by Abu Dhabi based LuLu Group International.
== Signs and symptoms == The only sign of vitiligo is the presence of pale, patchy areas of depigmented skin, which tend to occur on the extremities. Some people may experience itching before a new patch appears. The patches are initially small, but often grow and change shape. When skin lesions occur, they are most prominent on the face, hands, and wrists. The loss of skin pigmentation is particularly noticeable around body orifices, such as the mouth, eyes, nostrils, genitalia and umbilicus. Some lesions have increased skin pigment around the edges. Additionally, the hair of affected areas can turn white or gray due to the loss of melanin. Those affected by vitiligo who are stigmatized for their condition may experience depression and similar mood disorders. Vitiligo also appears in other mammals, being conspicuous for instance on Arabian horses.
== External links == Tree Family Betulaceae Diagnostic photos of many species, Morton Arboretum specimens Eichhorn, Markus (July 2010). "The Birch Tree". Test Tube. Brady Haran for the University of Nottingham.
However, fatty acids are also important components of the phospholipids that form the phospholipid bilayers out of which all the membranes of the cell are constructed (the cell wall, and the membranes that enclose all the organelles within the cells, such as the nucleus, the mitochondria, endoplasmic reticulum, and the Golgi apparatus). The "uncombined fatty acids" or "free fatty acids" found in the circulation of animals come from the breakdown (or lipolysis) of stored triglycerides. Because they are insoluble in water, these fatty acids are transported bound to plasma albumin. The levels of "free fatty acids" in the blood are limited by the availability of albumin binding sites. They can be taken up from the blood by all cells that have mitochondria (with the exception of the cells of the central nervous system). Fatty acids can only be broken down in mitochondria, by means of beta-oxidation followed by further combustion in the citric acid cycle to CO2 and water. Cells in the central nervous system, although they possess mitochondria, cannot take free fatty acids up from the blood, as the blood–brain barrier is impervious to most free fatty acids, excluding short-chain fatty acids and medium-chain fatty acids. These cells have to manufacture their own fatty acids from carbohydrates, as described above, in order to produce and maintain the phospholipids of their cell membranes, and those of their organelles.
Freeman John Dyson (15 December 1923 – 28 February 2020) was a British-American theoretical physicist and mathematician who worked in quantum field theory, astrophysics, random matrices, mathematical formulation of quantum mechanics, condensed matter physics, nuclear physics, and engineering. He was professor emeritus in the Institute for Advanced Study in Princeton and a member of the board of sponsors of the Bulletin of the Atomic Scientists. Dyson originated several concepts that bear his name, such as Dyson's transform, a fundamental technique in additive number theory, which he developed as part of his proof of Mann's theorem; the Dyson tree, a hypothetical genetically engineered plant capable of growing in a comet; the Dyson series, a perturbative series where each term is represented by Feynman diagrams; the Dyson sphere, a thought experiment that attempts to explain how a space-faring civilization would meet its energy requirements with a hypothetical megastructure that completely encompasses a star and captures a large percentage of its power output; and Dyson's eternal intelligence, a means by which an immortal society of intelligent beings in an open universe could escape the prospect of the heat death of the universe by extending subjective time to infinity while expending only a finite amount of energy. Drawing on Niels Bohr's principle of complementarity, he argued that science and spirituality were compatible. Dyson disagreed with the scientific consensus on climate change.
Sources: en.wikipedia.org
Nickel is obtained through extractive metallurgy: it is extracted from ore by conventional roasting and reduction processes that yield metal of greater than 75% purity. In many stainless steel applications, 75% pure nickel can be used without further purification, depending on impurities. Traditionally, most sulfide ores are processed using pyrometallurgical techniques to produce a matte for further refining. Hydrometallurgical techniques are also used. Most sulfide deposits have traditionally been processed by concentration through a froth flotation process followed by pyrometallurgical extraction. The nickel matte is further processed with the Sherritt-Gordon process. First, copper is removed by adding hydrogen sulfide, leaving a concentrate of cobalt and nickel. Then, solvent extraction is used to separate the cobalt and nickel, with the final nickel content greater than 86%. A second common refining process is leaching the metal matte into a nickel salt solution, followed by electrowinning the nickel from solution by plating it onto a cathode as electrolytic nickel.
In 2006 he finished the book Beyond the Setting Sun, with an introduction by Ranulph Fiennes, the renowned polar explorer and adventurer. The book was written to raise money for hospices in Britain, Canada and America.
=== Limitations === Removal limitations: If target ions are present in complex mixtures or at low concentrations, additional pre-treatment or post-treatment may be required. Regeneration requirements: Regeneration of ion exchange resins requires the use of chemicals and generates wastewater containing concentrated contaminants, which may require appropriate handling and disposal measures. Limited capacity: Ion exchange resins have finite capacities for adsorbing ions, and once saturated, they must be regenerated or replaced, which can limit their effectiveness in treating high-concentration or high-volume streams. Complexity: Ion exchange systems can be complex to design, operate, and maintain, requiring specialized knowledge and expertise.
Maria Atalioti, Chief Inspector, Sovereign Base Areas Police, Cyprus. For services to Policing, Diversity and Inclusion in the Sovereign Base Areas. Elliott Forbes, Deputy Commissioner, Royal Anguilla Police Force. For services to Policing in Anguilla.
Sources: en.wikipedia.org
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.
No approved regulatory indication exists in major markets. An approval exists for a different peptide, afamelanotide, which is used for a rare photosensitivity disorder called erythropoietic protoporphyria. Melanotan-2 itself remains a research compound with no cleared clinical role.
Melanocortin-1 receptors on melanocytes are the receptor most closely linked to pigment production. The peptide is not selective, however, and also activates melanocortin-3, melanocortin-4, and melanocortin-5 receptors. That lack of selectivity is the usual explanation offered for both its range of observed effects and its off-target effects.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.